IgniteData's system-agnostic technology, Archer, enables the fast, accurate transfer of patient data for clinical trials from EHR-to-EDC.
IgniteData has raised $9.2M in total funding. The most recent round was Series A. The last funding was announced in August 2025.
IgniteData's investors include FCA Venture Partners, The FSE Group, Innovate UK, Oncology Ventures, SpringTide Ventures.
IgniteData is headquartered in Maidenhead, United Kingdom.
IgniteData's system-agnostic technology, Archer, enables the fast, accurate transfer of patient data for clinical trials from EHR-to-EDC.
IgniteData is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IgniteData — Funding & Investors." VCBacked, August 14, 2025, https://www.vcbacked.co/company/ignitedata. Accessed July 19, 2026.
VCBacked. (2025). IgniteData — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ignitedata
{{cite web |title=IgniteData — Funding & Investors |url=https://www.vcbacked.co/company/ignitedata |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated